{"schema_version":"secwatch.filing_event.v1","accession":"0001688757-23-000053","form_type":"8-K","ticker":"ESTA","cik":"0001688757","company_name":"ESTABLISHMENT LABS HOLDINGS INC.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.048348+00:00","generated_at":"2026-06-15T13:39:19.005814+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Establishment Labs Q1 revenue $46.5M (+21% YoY), net loss widens to $11.9M","bullets":["Revenue $46.5M, record quarterly, up 21.0% YoY; currency-adjusted growth 22.9%.","Operating loss $8.2M vs $5.6M loss YoY; net loss $11.9M vs $5.9M loss YoY.","Cash $42.8M; completed follow-on offering April 27 with $90.4M gross proceeds.","2023 revenue guidance reaffirmed $200-210M, representing 24-30% YoY increase.","Mia Femtech launched in Japan April 10; Motiva IDE 3-year results presented."],"urls":{"canonical":"https://secwatch.observer/filing/0001688757-23-000053","json":"https://secwatch.observer/filing/0001688757-23-000053.json","markdown":"https://secwatch.observer/filing/0001688757-23-000053.md","text":"https://secwatch.observer/filing/0001688757-23-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000053/0001688757-23-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000053/esta-20230508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T13:39:19.005814+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1efba884b28a72c378241bc1764621975cbe8b08","claim":"ESTABLISHMENT LABS HOLDINGS INC. reported the first quarter ended March 31, 2023 results: revenue $46.5 million, net income $11.9 million. Guidance reaffirmed.","evidence_excerpt":"Establishment Labs Reports Record First Quarter 2023 Financial Results NEW YORK, NY, May 8, 2023 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2023. First Quarter Highlights and Outlook • First quarter worldwide revenue of $46.5 million increased 21.0% year-over-year and was a new quarterly record; excluding the impact of foreign currency changes, revenue growth in the first quarter would have been 22.9%. • 2023 revenue guidance remains $200 million to $210 million, an increase of 24% to 30% over 2022. • First quarter loss from operations was $8.2 million compared to a loss of $5.6 million in the year-ago period as investment in growth initiatives increased. • Cash balance of $42.8 million as of March 31, 2023. • Completed follow-on share offering on April 27, with gross","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1688757/000168875723000053/0001688757-23-000053-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$46.5 million"},{"label":"Net income","value":"$11.9 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}